Cited by 4,205Colorectal Cancer Surgical TreatmentsColorectal and Anal CarcinomasProstate Cancer Diagnosis and Treatment

Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer

Open access
Kapiteijn, Ellen, Marijnen, Corrie A.M., Nagtegaal, Iris D., Putter, Hein, Steup, Willem H., Wiggers, Theo, Rutten, Harm J.T., Pahlman, Lars +4 more·2001·New England Journal of Medicine

Abstract

BACKGROUND: Short-term preoperative radiotherapy and total mesorectal excision have each been shown to improve local control of disease in patients with resectable rectal cancer. We conducted a multicenter, randomized trial to determine whether the addition of preoperative radiotherapy increases the benefit of total mesorectal excision. METHODS: We randomly assigned 1861 patients with resectable rectal cancer either to preoperative radiotherapy (5 Gy on each of five days) followed by total mesorectal excision (924 patients) or to total mesorectal excision alone (937 patients). The trial was conducted with the use of standardization and quality-control measures to ensure the consistency of the radiotherapy, surgery, and pathological techniques. RESULTS: Of the 1861 patients randomly assigned to one of the two treatment groups, 1805 were eligible to participate. The overall rate of survival at two years among the eligible patients was 82.0 percent in the group assigned to both radiotherapy and surgery and 81.8 percent in the group assigned to surgery alone (P=0.84). Among the 1748 patients who underwent a macroscopically complete local resection, the rate of local recurrence at two years was 5.3 percent. The rate of local recurrence at two years was 2.4 percent in the radiotherapy-plus-surgery group and 8.2 percent in the surgery-only group (P<0.001). CONCLUSIONS: Short-term preoperative radiotherapy reduces the risk of local recurrence in patients with rectal cancer who undergo a standardized total mesorectal excision.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa010580

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the Dutch CKVO 95-04 trial, 5- and 10-year local control rates were significantly higher in the preoperative radiotherapy plus TME group than in the TME alone group.

    “the 5- and 10-year local control rates were significantly higher in the combination therapy group”

    From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [110]

    The Local Recurrence section reports significantly less local recurrence with preoperative radiotherapy plus TME than with TME alone, but only at two years (2.4% versus 8.2%; P<0.001). The Follow-up section says recurrence rates are presented at two years; this paper does not establish the claimed 5- or 10-year local-control rates. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • In the Dutch CKVO 95-04 trial, there was no significant difference between preoperative radiotherapy plus TME and TME alone in 5- and 10-year survival rates.

    “but there was no significant difference between the two groups in the 5- and 10-year survival rates [110–112].”

    From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [110]

    The Overall Survival section reports no significant difference between the groups at two years (P=0.84). The Discussion gives a median follow-up of 24.9 months, so this paper does not support the attributed finding about five- and ten-year survival. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 3

  1. [21]21. Erra- tum, N Engl J Med 1997;336:1539.]
  2. [36]36. Rao AR, Kagan AR, Chan PM, Gilbert HA, Nussbaum H, Hintz BL. Patterns of recurrence following curative resection alone for adenocarcino- ma of the rectum and sigmoid colon. Cancer 1981;48:1492-5.
  3. [39]39. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma: a prospective randomized trial. Cancer 1995;75:2269-75.

Cited by

Sorted by citations

Authors
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., Leer, J. W. H., & van de Velde, C. J. H.
Affiliations
  • Leiden University Medical Center (NL)
  • University Medical Center Groningen (NL)
  • Catharina Ziekenhuis (NL)
  • Uppsala University Hospital (SE)
  • Radboud University Medical Center (NL)
Venue
New England Journal of Medicine
Published
2001-08-30
Volume
345
Issue
9
Pages
638-646
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2132565869
Cited by
4,205
References
28
Citations by year
2026: 70 · 2025: 119 · 2024: 109 · 2023: 170 · 2022: 174 · 2021: 170 · 2020: 190 · 2019: 168 · 2018: 152 · 2017: 154 · 2016: 168 · 2015: 206 · 2014: 207 · 2013: 193 · 2012: 188
FWCI
58.56
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
  • Health Sciences › Medicine › Surgery › Colorectal and Anal Carcinomas
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Diagnosis and Treatment
Keywords
rectal cancer, preoperative radiotherapy, total mesorectal excision, local recurrence, resectable rectal cancer, survival, local control
MeSH terms
Adenocarcinoma, Adult, Aged, Aged, 80 and over, Analysis of Variance, Colorectal Surgery, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Preoperative Care, Prospective Studies, Rectal Neoplasms, Rectum, Survival Rate, Proportional Hazards Models, Radiotherapy, Adjuvant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review